Skip to main content
. 2024 May 13;22:7. doi: 10.1186/s13053-024-00277-5

Table 4a.

Hazard ratios for melanoma for some variables (BRCA1 subjects)

Variables Controls/ cases Univariate
HR (95%CI) P-value
Multivariate
HR (95%CI) P-value
Age at baseline in years
<=40 1237/5 1 1
41–50 1099/10 2.40 (0.82, 7.03) 0.11 1.90(0.63, 5.73) 0.26
>=51 1264/8 1.80 (0.59, 5.51) 0.30 1.47(0.46, 4.73) 0.52
Breast cancer at baseline
No 1969/10 1 1
Yes 1629/13 1.72 (0.76, 3.93) 0.20 1.61 (0.66, 3.92) 0.30
Hormone replacement therapy
No 2300/11 1 1
Yes 1299/12 1.65 (0.73, 3.74) 0.23 1.62 (0.68, 3.85) 0.28
Melanoma at baseline
No 3481/20 1 1
Yes 28/2 11.9 (2.78, 50.9) 0.0008 9.45 (2.16, 41.3) 0.003
Family history of melanoma
No 1406/13 1 1
Yes, melanoma 9/0 0 0
Country
Canada 1610/7 1 1
USA 1990/16 2.41 (1.00, 5.93) 0.05 1.26 (0.35–4.58) 0.73